# A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia

> **NCT06729320** · NA · NOT_YET_RECRUITING · sponsor: **Beijing GoBroad Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Refractory Immune Effector Cell-related Hemocytopenia

## Interventions

- **BIOLOGICAL:** Umbilical cord blood mononuclear cells
- **COMBINATION_PRODUCT:** Conventional hematopoietic recovery therapy

## Key facts

- **NCT ID:** NCT06729320
- **Lead sponsor:** Beijing GoBroad Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06729320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06729320, "A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06729320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*